Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng-Chun Yang

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
Blood|November 9, 2017
Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignanciesHui Yang, Stefan Kurtenbach, Ying Guo, et al.
Haematologica|March 26, 2017
An abnormal bone marrow microenvironment contributes to hematopoietic dysfunction in Fanconi anemiaYuan Zhou, Yongzheng He, Wen Xing, et al.
Leukemia|March 21, 2018
A novel ASXL1-OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignanciesDaichi Inoue, Takeshi Fujino, Paul Sheridan, et al.
Human Molecular Genetics|August 13, 2014
A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formationJeffrey R Gehlhausen, Su-Jung Park, Ann E Hickox, et al.
JCI Insight|October 8, 2021
p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemiaNa Man, Gloria Mas, Daniel L Karl, et al.
Nature Communications|June 9, 2017
Loss of Asxl2 leads to myeloid malignancies in miceJianping Li, Fuhong He, Peng Zhang, et al.
American Journal of Medical Genetics. Part A|September 19, 2009
Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic optionsFlorent Elefteriou, Mateusz Kolanczyk, Aaron Schindeler, et al.
American Journal of Medical Genetics. Part A|April 6, 2011
Multiple increased osteoclast functions in individuals with neurofibromatosis type 1David A Stevenson, Jincheng Yan, Yongzheng He, et al.
Cancer Cell|November 14, 2018
CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal HematopoiesisSarah M Greenblatt, Na Man, Pierre-Jacques Hamard, et al.
Cancer Cell|June 13, 2018
CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal HematopoiesisSarah M Greenblatt, Na Man, Pierre-Jacques Hamard, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Blood|November 9, 2017
Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignanciesHui Yang, Stefan Kurtenbach, Ying Guo, et al.
Haematologica|March 26, 2017
An abnormal bone marrow microenvironment contributes to hematopoietic dysfunction in Fanconi anemiaYuan Zhou, Yongzheng He, Wen Xing, et al.
Leukemia|March 21, 2018
A novel ASXL1-OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignanciesDaichi Inoue, Takeshi Fujino, Paul Sheridan, et al.
Human Molecular Genetics|August 13, 2014
A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formationJeffrey R Gehlhausen, Su-Jung Park, Ann E Hickox, et al.
JCI Insight|October 8, 2021
p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemiaNa Man, Gloria Mas, Daniel L Karl, et al.
Nature Communications|June 9, 2017
Loss of Asxl2 leads to myeloid malignancies in miceJianping Li, Fuhong He, Peng Zhang, et al.
American Journal of Medical Genetics. Part A|September 19, 2009
Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic optionsFlorent Elefteriou, Mateusz Kolanczyk, Aaron Schindeler, et al.
American Journal of Medical Genetics. Part A|April 6, 2011
Multiple increased osteoclast functions in individuals with neurofibromatosis type 1David A Stevenson, Jincheng Yan, Yongzheng He, et al.
Cancer Cell|November 14, 2018
CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal HematopoiesisSarah M Greenblatt, Na Man, Pierre-Jacques Hamard, et al.
Cancer Cell|June 13, 2018
CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal HematopoiesisSarah M Greenblatt, Na Man, Pierre-Jacques Hamard, et al.
Pageof 13